Nanologica
1,72
SEK
+4,88 %
Mindre end 1K følgere
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+4,88%
-18,1%
-5,49%
-3,1%
-26,02%
-73,97%
-88%
-77,05%
-90,52%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Læs mereMarkedsværdi
151,97 mio. SEK
Aktieomsætning
4,81 t SEK
Omsætning
14,54 mio.
EBIT %
-407,57 %
P/E
-
Udbytteafkast, %
-
Finanskalender
17.4
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
11.7
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Year-End Report 2024 Nanologica AB (publ)
Change of Dates for Year-End Report 2024 for Nanologica AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools